房颤吃10mg利伐沙班片有用吗,效果如何？

Non-valvular atrial fibrillation is relatively common in cardiovascular medicine. It carries the risk of ischemic stroke and can pose a serious threat to patients' health. It is an Xa inhibitor that has been used clinically in recent years. It can be effective in a short time and the blood concentration is relatively stable. So, is it useful to take 10 mg Rivaroxaban tablets for atrial fibrillation? What is the effect?

Is it useful to take 10mg rivaroxaban tablets for patients with atrial fibrillation?

It is generally useful for patients with atrial fibrillation to take 10mg rivaroxaban tablets. Patients with atrial fibrillation take rivaroxaban to prevent blood clots and the harm of atrial fibrillation. Patients with atrial fibrillation are prone to blood clots because during atrial fibrillation, the atria have almost no normal systolic and diastolic functions. The atria are close to the atrial wall, especially the left atrial appendage, and the blood flow rate is relatively slow, making it easy to form thrombi. This drug is commonly used to prevent blood clots in patients with atrial fibrillation and needs to be taken for a long time.

How effective is Rivaroxaban tablets?

Select 30 patients each with rivaroxaban (set as the observation group) and warfarin (set as the control group) patients aged ≥60 years old with non-valvular atrial fibrillation and hypertensive coronary heart disease to analyze the application effects of the two groups.

Results: The total incidence of minor bleeding events in the observation group after treatment was lower than that in the control group (P≤0.05); the total incidence of non-major bleeding events, major bleeding events, embolic events, and gastrointestinal reactions in the observation group were compared with the control group (P>0.05); the PT and APTT levels in the observation group after treatment were compared with those in the control group (P<0.05), and the TT and FIB levels were compared with those in the control group (P>0.05). ; Comparison of ALT, AST and TBIL in the observation group before and after treatment with the control group (P>0.05).

It is concluded that long-term treatment with rivaroxaban is effective and safe in elderly patients with non-valvular atrial fibrillation and hypertensive coronary heart disease.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: